GPD1L antibody (AA 1-351)

Catalog No. ABIN5776141

The Mouse Monoclonal anti-GPD1L antibody has been validated for WB, ELISA, ICC and IF. It is suitable to detect GPD1L in samples from Human.

Quick Overview for GPD1L antibody (AA 1-351) (ABIN5776141)

Target: GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This GPD1L antibody is un-conjugated

Application: Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)

Clone: AT14E2

Product Details anti-GPD1L Antibody

Binding Specificity: AA 1-351

Immunogen: Recombinant human GPD1L (1-351aa) purified from E. coli

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.

Target Details for GPD1L

Target: GPD1L (Glycerol-3-Phosphate Dehydrogenase 1-Like (GPD1L))

Alternative Name: GPD1L

Background: GPD1L is converts sn-glycerol 3-phosphate to glycerone phosphate. This protein is found in the cytoplasm, associated with the plasma membrane, where it binds the sodium channel, voltage-gated, type V, alpha subunit (SCN5A). GPD1L is thought to affect trafficking of the cardiac sodium current to the cell surface. Mutations in GPD1L are the cause of sudden infant death syndrome (SIDS) and Brugada syndrome type 2, an autosomal dominant tachyarrhythmia.

NCBI Accession: NP_055956